Anthropometrics of Polish children with osteogenesis imperfecta: a single-centre retrospective cohort study

Abstract Background Osteogenesis imperfecta (OI) causes a number of abnormalities in somatic development. The predominant symptoms are reduced bone mass and an increased risk of fractures as well as bone deformities and short stature. Due to the lack of causal treatment options, bisphosphonates are...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. Jakubowska-Pietkiewicz (Autor), A. Maćkowska (Autor), J. Nowicki (Autor), E. Woźniak (Autor), Nowicki Jakub (Autor)
Formato: Libro
Publicado: BMC, 2022-10-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a28af480a05a41ab9f846bd6d294943f
042 |a dc 
100 1 0 |a E. Jakubowska-Pietkiewicz  |e author 
700 1 0 |a A. Maćkowska  |e author 
700 1 0 |a J. Nowicki  |e author 
700 1 0 |a E. Woźniak  |e author 
700 1 0 |a Nowicki Jakub  |e author 
245 0 0 |a Anthropometrics of Polish children with osteogenesis imperfecta: a single-centre retrospective cohort study 
260 |b BMC,   |c 2022-10-01T00:00:00Z. 
500 |a 10.1186/s12887-022-03621-7 
500 |a 1471-2431 
520 |a Abstract Background Osteogenesis imperfecta (OI) causes a number of abnormalities in somatic development. The predominant symptoms are reduced bone mass and an increased risk of fractures as well as bone deformities and short stature. Due to the lack of causal treatment options, bisphosphonates are considered the gold standard of therapy. The aim of our study is to present selected anthropometric parameters (body weight, height, BMI) in children with type I and III of OI. Methods We performed a retrospective analysis of medical records of patients with osteogenesis imperfecta type I and III confirmed by genetic testing. The study group included individuals admitted to the Department in 2020. We analysed the anthropometric parameters of 108 children (receiving and not receiving bisphosphonates treatment). Results In the group of children with OI type I admitted for follow-up (group 1), the median weight percentile was 37, while in the group 2 it was 17. In the patients with OI type III (group 3), the median weight percentile was 0.1. The median height percentile in group 1 was 21, in group 2 it was 5, whereas in group 3 = 0.1. The differences in anthropometric measurements of the patients with OI type I and OI type III were statistically significant (p < 0.001). Among the analysed patients, an abnormal BMI was found in 41.67% of whom 37.78% were underweight, 48.89% were overweight and 13.33% were obese. Conclusion Considering prevalence of the disease, it is not only low stature but also abnormal BMI, and especially excessive body weight, that play an important role in the somatic development disorder. 
546 |a EN 
690 |a Osteogenesis imperfecta 
690 |a Obesity 
690 |a BMI 
690 |a Body weight 
690 |a Height 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n BMC Pediatrics, Vol 22, Iss 1, Pp 1-5 (2022) 
787 0 |n https://doi.org/10.1186/s12887-022-03621-7 
787 0 |n https://doaj.org/toc/1471-2431 
856 4 1 |u https://doaj.org/article/a28af480a05a41ab9f846bd6d294943f  |z Connect to this object online.